| Latest News and Updates |
Press Releases
Featured Press Release
BioEclipse Therapeutics™ Awarded Grant to Fund Cancer Immunotherapy Clinical Trial
BioEclipse Therapeutics™ Awarded $8 Million Grant by CIRM to Fund Ongoing Phase 1 CRX100 Cancer Immunotherapy Clinical Trial...
Read Article
Read Article
BioEclipse Therapeutics™ Awarded Grant to Fund Cancer Immunotherapy Clinical Trial
BioEclipse Therapeutics™ Awarded $8 Million Grant by CIRM to Fund Ongoing Phase 1 CRX100 Cancer Immunotherapy Clinical Trial...
Read Article
Read Article
Remedium Bio invited to showcase pipeline at the 2021 Life Sciences Summit
Read
read
Remedium Bio invited to showcase pipeline at the 2021 Life Sciences Summit
Read
read
CH4 Global Named on the 2023 Global Cleantech 100 Exceptional Innovators with the Determination and Technologies to Race to Net-Zero
Read
read
CH4 Global Named on the 2023 Global Cleantech 100 Exceptional Innovators with the Determination and Technologies to Race to Net-Zero
Read
read
Bantam Pharmaceutical to present at Biotech Showcase 2023
Read
read
Bantam Pharmaceutical to present at Biotech Showcase 2023
Read
read
Designing Immunotherapies that can overcome recurrence and resistance
Read
read
Designing Immunotherapies that can overcome recurrence and resistance
Read
read
PineTree Therapeutics Receives a Bits and Bytes Grant from Massachusetts Life Sciences Center
Read
read
PineTree Therapeutics Receives a Bits and Bytes Grant from Massachusetts Life Sciences Center
Read
read
BioEclipse Therapeutics Appoints New Board Member and Names Interim CFO
Read
read
BioEclipse Therapeutics Appoints New Board Member and Names Interim CFO
Read
read
Allogene and Antion collaborate on Multiplex miCAR Tech
Read
read
Allogene and Antion collaborate on Multiplex miCAR Tech
Read
read
Remedium Bio, Inc. announces research agreement to evaluate platform technology in Diabetes with the University of Massachusetts Boston
Read
read
Remedium Bio, Inc. announces research agreement to evaluate platform technology in Diabetes with the University of Massachusetts Boston
Read
read
Nodes Invited to Attend the 2021 Biofit Conference Programme
Read
read
Nodes Invited to Attend the 2021 Biofit Conference Programme
Read
read
Scioto Biosciences, Inc. Announces First Patient Dosed in Phase Ib Study in Patients Diagnosed with Autistic Disorder
Read
read
Scioto Biosciences, Inc. Announces First Patient Dosed in Phase Ib Study in Patients Diagnosed with Autistic Disorder
Read
read
Nodes Advisors Will Be in Attendance at Lsi2021 Emerging Medtech Summit
Read
read
Nodes Advisors Will Be in Attendance at Lsi2021 Emerging Medtech Summit
Read
read
Nodes Advisors selected to speak at the Festival Biologics 2020 Conference in Basel
Read
read
Nodes Advisors selected to speak at the Festival Biologics 2020 Conference in Basel
Read
read
Scioto Biosciences and Abigail Wexner Research Institute at Nationwide Children’s Hospital Receive a $2.3 Million Dollar Phase II SBIR Grant to Develop Novel Therapy
Read
read
Scioto Biosciences and Abigail Wexner Research Institute at Nationwide Children’s Hospital Receive a $2.3 Million Dollar Phase II SBIR Grant to Develop Novel Therapy
Read
read
Get in touch
Contact us for more information about how we can help you invest in healthcare, biotech, climate tech, or advanced systems.